Diagnostic Nuclear Drug Market, Global Outlook and Forecast 2023-2029

Report ID: MMG175124 | Category: Pharma & Healthcare | Pages: 63 | Format: PDF | Published Date: August 16,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
This report aims to provide a comprehensive presentation of the global market for Diagnostic Nuclear Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Nuclear Drug. This report contains market size and forecasts of Diagnostic Nuclear Drug in global, including the following market information:
Global Diagnostic Nuclear Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diagnostic Nuclear Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Tc-99m Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diagnostic Nuclear Drug include Bracco Imaging, Bayer, Curium Pharmaceuticals, Nordion, Triad Isotopes, Lantheus, GE Healthcare, China Isotope & Radiation and Jubilant Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diagnostic Nuclear Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diagnostic Nuclear Drug Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diagnostic Nuclear Drug Market Segment Percentages, by Type, 2022 (%)
    Tc-99m
    F-18
    Other
Global Diagnostic Nuclear Drug Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diagnostic Nuclear Drug Market Segment Percentages, by Application, 2022 (%)
    Oncology
    Cardiology
    Other
Global Diagnostic Nuclear Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diagnostic Nuclear Drug Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diagnostic Nuclear Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diagnostic Nuclear Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Bracco Imaging
    Bayer
    Curium Pharmaceuticals
    Nordion
    Triad Isotopes
    Lantheus
    GE Healthcare
    China Isotope & Radiation
    Jubilant Pharma
    Eli Lilly
    Novartis
    SIEMENS
    Dongcheng
    Navidea
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diagnostic Nuclear Drug, market overview.
Chapter 2: Global Diagnostic Nuclear Drug market size in revenue.
Chapter 3: Detailed analysis of Diagnostic Nuclear Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diagnostic Nuclear Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Diagnostic Nuclear Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Diagnostic Nuclear Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Diagnostic Nuclear Drug Overall Market Size
    2.1 Global Diagnostic Nuclear Drug Market Size: 2022 VS 2029
    2.2 Global Diagnostic Nuclear Drug Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Diagnostic Nuclear Drug Players in Global Market
    3.2 Top Global Diagnostic Nuclear Drug Companies Ranked by Revenue
    3.3 Global Diagnostic Nuclear Drug Revenue by Companies
    3.4 Top 3 and Top 5 Diagnostic Nuclear Drug Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Diagnostic Nuclear Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Diagnostic Nuclear Drug Players in Global Market
        3.6.1 List of Global Tier 1 Diagnostic Nuclear Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 Diagnostic Nuclear Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Diagnostic Nuclear Drug Market Size Markets, 2022 & 2029
        4.1.2 Tc-99m
        4.1.3 F-18
        4.1.4 Other
    4.2 By Type - Global Diagnostic Nuclear Drug Revenue & Forecasts
        4.2.1 By Type - Global Diagnostic Nuclear Drug Revenue, 2018-2023
        4.2.2 By Type - Global Diagnostic Nuclear Drug Revenue, 2024-2029
        4.2.3 By Type - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Diagnostic Nuclear Drug Market Size, 2022 & 2029
        5.1.2 Oncology
        5.1.3 Cardiology
        5.1.4 Other
    5.2 By Application - Global Diagnostic Nuclear Drug Revenue & Forecasts
        5.2.1 By Application - Global Diagnostic Nuclear Drug Revenue, 2018-2023
        5.2.2 By Application - Global Diagnostic Nuclear Drug Revenue, 2024-2029
        5.2.3 By Application - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Diagnostic Nuclear Drug Market Size, 2022 & 2029
    6.2 By Region - Global Diagnostic Nuclear Drug Revenue & Forecasts
        6.2.1 By Region - Global Diagnostic Nuclear Drug Revenue, 2018-2023
        6.2.2 By Region - Global Diagnostic Nuclear Drug Revenue, 2024-2029
        6.2.3 By Region - Global Diagnostic Nuclear Drug Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Diagnostic Nuclear Drug Revenue, 2018-2029
        6.3.2 US Diagnostic Nuclear Drug Market Size, 2018-2029
        6.3.3 Canada Diagnostic Nuclear Drug Market Size, 2018-2029
        6.3.4 Mexico Diagnostic Nuclear Drug Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Diagnostic Nuclear Drug Revenue, 2018-2029
        6.4.2 Germany Diagnostic Nuclear Drug Market Size, 2018-2029
        6.4.3 France Diagnostic Nuclear Drug Market Size, 2018-2029
        6.4.4 U.K. Diagnostic Nuclear Drug Market Size, 2018-2029
        6.4.5 Italy Diagnostic Nuclear Drug Market Size, 2018-2029
        6.4.6 Russia Diagnostic Nuclear Drug Market Size, 2018-2029
        6.4.7 Nordic Countries Diagnostic Nuclear Drug Market Size, 2018-2029
        6.4.8 Benelux Diagnostic Nuclear Drug Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Diagnostic Nuclear Drug Revenue, 2018-2029
        6.5.2 China Diagnostic Nuclear Drug Market Size, 2018-2029
        6.5.3 Japan Diagnostic Nuclear Drug Market Size, 2018-2029
        6.5.4 South Korea Diagnostic Nuclear Drug Market Size, 2018-2029
        6.5.5 Southeast Asia Diagnostic Nuclear Drug Market Size, 2018-2029
        6.5.6 India Diagnostic Nuclear Drug Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Diagnostic Nuclear Drug Revenue, 2018-2029
        6.6.2 Brazil Diagnostic Nuclear Drug Market Size, 2018-2029
        6.6.3 Argentina Diagnostic Nuclear Drug Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Diagnostic Nuclear Drug Revenue, 2018-2029
        6.7.2 Turkey Diagnostic Nuclear Drug Market Size, 2018-2029
        6.7.3 Israel Diagnostic Nuclear Drug Market Size, 2018-2029
        6.7.4 Saudi Arabia Diagnostic Nuclear Drug Market Size, 2018-2029
        6.7.5 UAE Diagnostic Nuclear Drug Market Size, 2018-2029
7 Diagnostic Nuclear Drug Companies Profiles
    7.1 Bracco Imaging
        7.1.1 Bracco Imaging Company Summary
        7.1.2 Bracco Imaging Business Overview
        7.1.3 Bracco Imaging Diagnostic Nuclear Drug Major Product Offerings
        7.1.4 Bracco Imaging Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.1.5 Bracco Imaging Key News & Latest Developments
    7.2 Bayer
        7.2.1 Bayer Company Summary
        7.2.2 Bayer Business Overview
        7.2.3 Bayer Diagnostic Nuclear Drug Major Product Offerings
        7.2.4 Bayer Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.2.5 Bayer Key News & Latest Developments
    7.3 Curium Pharmaceuticals
        7.3.1 Curium Pharmaceuticals Company Summary
        7.3.2 Curium Pharmaceuticals Business Overview
        7.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Major Product Offerings
        7.3.4 Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.3.5 Curium Pharmaceuticals Key News & Latest Developments
    7.4 Nordion
        7.4.1 Nordion Company Summary
        7.4.2 Nordion Business Overview
        7.4.3 Nordion Diagnostic Nuclear Drug Major Product Offerings
        7.4.4 Nordion Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.4.5 Nordion Key News & Latest Developments
    7.5 Triad Isotopes
        7.5.1 Triad Isotopes Company Summary
        7.5.2 Triad Isotopes Business Overview
        7.5.3 Triad Isotopes Diagnostic Nuclear Drug Major Product Offerings
        7.5.4 Triad Isotopes Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.5.5 Triad Isotopes Key News & Latest Developments
    7.6 Lantheus
        7.6.1 Lantheus Company Summary
        7.6.2 Lantheus Business Overview
        7.6.3 Lantheus Diagnostic Nuclear Drug Major Product Offerings
        7.6.4 Lantheus Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.6.5 Lantheus Key News & Latest Developments
    7.7 GE Healthcare
        7.7.1 GE Healthcare Company Summary
        7.7.2 GE Healthcare Business Overview
        7.7.3 GE Healthcare Diagnostic Nuclear Drug Major Product Offerings
        7.7.4 GE Healthcare Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.7.5 GE Healthcare Key News & Latest Developments
    7.8 China Isotope & Radiation
        7.8.1 China Isotope & Radiation Company Summary
        7.8.2 China Isotope & Radiation Business Overview
        7.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Major Product Offerings
        7.8.4 China Isotope & Radiation Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.8.5 China Isotope & Radiation Key News & Latest Developments
    7.9 Jubilant Pharma
        7.9.1 Jubilant Pharma Company Summary
        7.9.2 Jubilant Pharma Business Overview
        7.9.3 Jubilant Pharma Diagnostic Nuclear Drug Major Product Offerings
        7.9.4 Jubilant Pharma Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.9.5 Jubilant Pharma Key News & Latest Developments
    7.10 Eli Lilly
        7.10.1 Eli Lilly Company Summary
        7.10.2 Eli Lilly Business Overview
        7.10.3 Eli Lilly Diagnostic Nuclear Drug Major Product Offerings
        7.10.4 Eli Lilly Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.10.5 Eli Lilly Key News & Latest Developments
    7.11 Novartis
        7.11.1 Novartis Company Summary
        7.11.2 Novartis Business Overview
        7.11.3 Novartis Diagnostic Nuclear Drug Major Product Offerings
        7.11.4 Novartis Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.11.5 Novartis Key News & Latest Developments
    7.12 SIEMENS
        7.12.1 SIEMENS Company Summary
        7.12.2 SIEMENS Business Overview
        7.12.3 SIEMENS Diagnostic Nuclear Drug Major Product Offerings
        7.12.4 SIEMENS Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.12.5 SIEMENS Key News & Latest Developments
    7.13 Dongcheng
        7.13.1 Dongcheng Company Summary
        7.13.2 Dongcheng Business Overview
        7.13.3 Dongcheng Diagnostic Nuclear Drug Major Product Offerings
        7.13.4 Dongcheng Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.13.5 Dongcheng Key News & Latest Developments
    7.14 Navidea
        7.14.1 Navidea Company Summary
        7.14.2 Navidea Business Overview
        7.14.3 Navidea Diagnostic Nuclear Drug Major Product Offerings
        7.14.4 Navidea Diagnostic Nuclear Drug Revenue in Global Market (2018-2023)
        7.14.5 Navidea Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Diagnostic Nuclear Drug Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?